Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,396 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, Business Operations gave up 1,964 shares (to pay taxes)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award EVP, Quality & Ethics, and CPL acquired 96,310 shares (grant or award)
  5. 4 Grant or award EVP, Ext Aff, GC, Corp Sec acquired 56,180 shares (grant or award)
  6. 4 Open-market sale Director sold 1,912 shares at $11.94 ($22,829)
  7. 4 Shares withheld for taxes EVP, Ext Aff, GC, Corp Sec gave up 416 shares (to pay taxes)
  8. 4 Grant or award Director acquired 11,852 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale Director sold 1,173 shares at $31.52 ($36,973)
  11. 4 Grant or award Director acquired 8,446 shares (grant or award)
  12. 4 Grant or award Director acquired 8,446 shares (grant or award)
  13. 4 Grant or award Director acquired 8,446 shares (grant or award)
  14. 4 Grant or award Director acquired 8,446 shares (grant or award)
  15. 4 Grant or award Director acquired 8,446 shares (grant or award)
  16. 4 Grant or award Director acquired 8,446 shares (grant or award)
  17. 4 Grant or award Director acquired 8,446 shares (grant or award)
  18. 4 Open-market sale Director sold 1,996 shares at $35.53 ($70,918)
  19. 4 Grant or award EVP, Quality & Ethics, and CPL acquired 11,826 shares (grant or award)
  20. 4 Grant or award Director acquired 8,595 shares (grant or award)

Page 10 of 49 · 970 filings